Lexology June 2, 2023
We are pleased to present the first issue of our newsletter analyzing recent trends and developments impacting the life sciences industry, including DOJ policy updates and key provisions of the Food and Drug Omnibus Reform Act.
- What Life Sciences Companies Need To Know About Recent Changes to DOJ Policies
- FDA Enforcement
- FDA Regulatory
- HHS Compliance
- FCA Enforcement
What Life Sciences Companies Need To Know About Recent Changes to DOJ Policies
In the first quarter of 2023, the Department of Justice (DOJ) announced a series of updates to existing policies, as well as some entirely new policies, relating to the prosecution of corporate crime and the corresponding evaluation of corporate compliance programs.
These DOJ policies apply across industries, but...